MDM2 amplification has broad consequences, primarily in the rapid ubiquitination and proteasomal degradation of p53, thereby effectively silencing p53-mediated transcriptional programs and neutralizing its tumor-suppressor properties [44,60]. The gene discussed is MDM2; the disease is neoplasm.